Bosentan Tablet, For Suspension
Product Images NDC 70710-1508

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bosentan (NDC 70710-1508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 01)

This text is a list of interacting drugs, including Cyclosporin A, Glipride, Simvastatin, Hyoroxy acid simvastatin, Norethindrone, Ethinyl estradiol, and additional information on fold-change of interacting drugs and recommendations for usage. It advises on the consideration of potential contraindications, cholesterol levels, and the importance of additional contraception.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 02)

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 03)

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 04)

The text provided lists recommendations for interacting drugs based on their impact on various pharmacokinetic parameters like Cmax and AUC, as well as enzyme induction involving CYP3A and CYP2C9. It suggests adjustments or additional precautions for drugs like Cyclosporin, Glyburide, Simvastatin, Digoxin, Sildenafil, Warfarin, Norethindrone, Ethinylestradiol, Nimodipine, and Tadalafil. It also mentions monitoring cholesterol levels and the need for additional contraception in certain cases.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 05)

This text contains information about drug interactions involving various medications such as Cyclosporin A, Lopinavir, Rifampin, Ketoconazole, Losartan, Sildenafil, and Tadalafil. It also mentions the impact on different enzymes like CYP3A and OATP, as well as recommendations for contraindication, dose reduction, and adjustments for optimal therapeutic outcomes.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 06)

This appears to be a list of different sections or categories related to meters and bassline. It seems to contain information organized by week, possibly indicating progression or a schedule.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 07)

This is a graph showing the comparison between Bosentan and Placebo over time (in weeks). Bosentan appears to have a positive impact, with a percentage increase of 89%. The p-value is 0.00015 and the difference in efficacy is highlighted.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 08)

This text appears to be a list of information related to Bosentan Tablet for Oral Suspension distributed by Zydus Pharmaceuticals (USA) Inc. The text includes lot numbers, expiration dates, and the amount of Phenylalanine per tablet. It also mentions the product being made in India and distributed in Pennington, NJ. Please note that this text does not contain complete sentences and is primarily composed of product details and distribution information.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 09)

This text provides information about a medication with the NDC code 70710-1508-8, containing 32 mg of anhydrous bosentan. The usual dosage involves dispersing tablets in water before administration. The text also includes storage instructions, directions for opening the packaging, and mentions that the package is child-resistant. It is advised to keep the medication out of the reach of children. Furthermore, it includes details about the manufacturer, Zydus Lifescences Ltd., based in India, and distributor, Zydus Pharmaceuticals (USA) Inc. The full prescribing information is enclosed with the product.*

FDA Label Image

Image (A4b3663e 948c 4d0d 9916 237b5597ad9f 188 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.